0.9899
전일 마감가:
$1.25
열려 있는:
$1.23
하루 거래량:
2.33M
Relative Volume:
1.46
시가총액:
$5.24M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+16.16%
1개월 성능:
-98.73%
6개월 성능:
-99.58%
1년 성능:
+0.00%
Polyrizon Ltd Stock (PLRZ) Company Profile
PLRZ을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PLRZ
Polyrizon Ltd
|
0.9829 | 14,625 | 0 | 0 | 0 | 0.00 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.37 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
440.20 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
79.34 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
488.56 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Polyrizon Ltd 주식(PLRZ)의 최신 뉴스
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Eagle-Tribune
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Promising Small Cap Stocks To Follow NowMay 4th - MarketBeat
Best Small Cap Stocks To ConsiderMay 3rd - MarketBeat
Polyrizon Ltd. Announces 1-for-10 Reverse Share Split Effective May 5, 2025 - TipRanks
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest By Stocktwits - Investing.com India
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
Promising Biotech Stocks To Watch Today – May 2nd - Defense World
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
PLRZ Stock: Exploring Polyrizon Ltd’s Growth - investchronicle.com
Polyrizon (PLRZ) Stock Skyrocketed Over 240% Today: What's Going On? - Benzinga
PLRZ’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
S&P 500 Gains 1%; April Jobs Top Expectations - Benzinga
Polyrizon Ltd (NASDAQ: PLRZ) Down -12.0% From 52-Week Low; YTD Falls -88.32% – Here’s What To Do Now - Marketing Sentinel
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment - The Manila Times
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ) - ACCESS Newswire
PLRZ’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Polyrizon advances nasal allergy blocker safety study By Investing.com - Investing.com South Africa
How does PLRZ’s price to cash per share ratio compare in the market? - uspostnews.com
Polyrizon advances nasal allergy blocker safety study - Investing.com
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model - The Manila Times
Polyrizon Achieves Milestone with Successful Safety Study of PL-14 - TipRanks
Polyrizon Ltd. Announces Successful Preliminary Safety Study for PL-14 Allergy Blocker Intranasal Hydrogel - Nasdaq
Polyrizon Ltd (PLRZ) 재무 분석
Polyrizon Ltd (PLRZ)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):